Ameriprise
HQCL

Ameriprise’s Hanwha Q CELLS Co., Ltd. HQCL Stock Holding History

Ameriprise’s Portfolio HQCL Stock Details HQCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-8
Closed – – 4778
2014
Q3 		$0 Buy
8
+4
+100% +$92 ﹤0.01% 5957
2014
Q2 		$0 Buy
4
+3
+300% +$77 ﹤0.01% 5724
2014
Q1 		$0 Buy
+1
New +$31 ﹤0.01% 5454
2013
Q4 		– Hold
0
– – – 5555
2013
Q3 		– Hold
0
– – – 5712
2013
Q2 		– Hold
0
– – – 5597

Other funds holding HQCL

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SCM
Seamans Capital Management Boston, Massachusetts $30.2M AUM 15.76% 1-Year Est. Return
FA
FDx Advisors Chicago, Illinois $313M AUM 18.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Ameriprise's HQCL Position: Q4 2014 in Review

Ameriprise sold out of Hanwha Q CELLS Co., Ltd. (HQCL) in Q4 2014, closing a stake of 8 shares.

Ameriprise first reported a position in HQCL in Q1 2014 and held it in 3 quarters. The position peaked at $0 in Q3 2014. 39 funds tracked by Wall St. Rank hold HQCL as of Q4 2014.

  • Ameriprise reported no remaining Hanwha Q CELLS Co., Ltd. position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 8 Hanwha Q CELLS Co., Ltd. shares in Q4 2014.
  • Ameriprise first reported a position in Hanwha Q CELLS Co., Ltd. in Q1 2014 and held it in 3 quarters.
  • Ameriprise's Hanwha Q CELLS Co., Ltd. position peaked at $0 in Q3 2014.
  • 39 funds tracked by Wall St. Rank held Hanwha Q CELLS Co., Ltd. as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.